Nu Skin Enterprises, Inc. reports developments tied to its beauty and wellness business, affiliate opportunity platform and international market operations. Company updates commonly cover quarterly revenue and earnings, customer, paid affiliate and sales leader trends, dividend declarations, cost discipline and product commercialization across Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging brands.
Recurring news also includes the rollout of Prysm iO, an intelligent wellness platform that uses skin scans to provide antioxidant-related insights, and activity at Rhyz, the company’s strategic investment arm for consumer, technology and manufacturing businesses in beauty, wellness and lifestyle categories. Leadership appointments and operating-structure changes are also part of the company’s public updates.
Nu Skin Enterprises, Inc. (NYSE: NUS) has announced that its ageLOC® LumiSpa® iO has won the 2022 "New Product of the Year" award from the Business Intelligence Group. This beauty and cleansing device, recognized for its innovative micropulse oscillation technology, connects to the Nu Skin Vera app to enhance personalized skincare experiences. The LumiSpa iO has contributed to Nu Skin's status as the leading brand in beauty device systems for five consecutive years. The awards highlight innovations aiming to transform consumer experiences.
Nu Skin Enterprises (NYSE: NUS) unveiled the ageLOC® LumiSpa® iO, a smart skin treatment and cleansing device, on November 17, 2022, in Provo, Utah. This device features patented micropulse technology, offering personalized skincare options, intelligent coaching, and routine tracking through the Nu Skin Vera app. Users can create customized facial treatments and track their progress, with clinical studies noting user improvements in skin softness (58%), smoothness (47%), brightness (40%), and radiance (34%). The device is designed for daily use and is available now in the U.S.
Summary not available.
Nu Skin Enterprises (NUS) reported Q3 2022 revenue of $537.8 million, representing a 16% decline compared to Q3 2021, impacted by foreign exchange losses and macroeconomic conditions. EPS was $(0.51), significantly down from $0.97 in the same quarter last year. Customer numbers fell by 11% to 1.24 million. The company anticipates Q4 revenue in the range of $500 to $550 million and full-year revenue of $2.20 to $2.25 billion. Despite challenges, Nu Skin remains focused on long-term growth strategies.
Nu Skin Enterprises, Inc. (NYSE: NUS) has announced a quarterly cash dividend of $0.385 per share, to be paid on December 7, 2022, to shareholders of record as of November 25, 2022. This action demonstrates the company's commitment to returning value to shareholders while maintaining a focus on its global integrated beauty and wellness business, which operates in approximately 50 markets worldwide. Nu Skin is also committed to sustainability, aiming for reduced and sustainable packaging by 2030.
Nu Skin Enterprises (NYSE: NUS) will release its third quarter financial results on November 2, 2022, after market close. A conference call for investors is scheduled for 5 p.m. ET on the same day, where management will discuss the quarterly performance and upcoming initiatives. The company operates globally with a focus on innovation in beauty and wellness products, backed by over 35 years of scientific research. Nu Skin is also dedicated to sustainability, aiming for reduced packaging by 2030.
Nu Skin Enterprises, Inc. (NYSE: NUS) announced on September 21, 2022, that Dr. Helen Knaggs was honored as one of the 2022 Women of the Year by Utah Business magazine. Dr. Knaggs, with over 30 years in product research, leads a diverse R&D team at Nu Skin and has made significant contributions to anti-aging research. She actively supports women in STEM careers and chairs the Women Rising employee resource group. This recognition underscores her commitment to innovation and community empowerment, contributing positively to Nu Skin's reputation and corporate culture.
Nu Skin Enterprises, Inc. (NUS) reported Q2 2022 revenue of $560.6 million, a decrease of 20% year-over-year, with a foreign exchange impact of $34.6 million. EPS stood at $0.67, down from $1.15 in Q2 2021. Key metrics included a 6% drop in customers and a 16% decline in paid affiliates. The company faced challenges from COVID-19 in China, global economic conditions, and a strong U.S. dollar. For Q3 2022, revenue is projected between $550 to $590 million, and EPS is estimated at $0.04 to $0.22. Strategic measures are planned for cost savings and to support Nu Vision 2025.
Nu Skin Enterprises (NYSE: NUS) declared a quarterly cash dividend of $0.385 per share, scheduled for payment on Sept. 7, 2022, to shareholders of record on Aug. 26, 2022. This reflects the company's ongoing commitment to return value to its investors. Operating in approximately 50 global markets, Nu Skin provides innovative wellness and beauty products backed by over 35 years of scientific research. The company emphasizes sustainability, aiming to transition to reduced and sustainable packaging by 2030.
Nu Skin Enterprises has announced estimated second quarter revenue between $557 million and $562 million, which is lower than expected due to several factors including COVID-19 impacts in Mainland China, the ongoing conflict in Russia and Ukraine, and a general economic downturn affecting developing regions like Latin America.
Despite these challenges, growth was noted in Southeast Asia and the U.S. The company remains optimistic about its EmpowerMe strategy and the upcoming launch of the ageLOC LumiSpa iO device, anticipating improvements in the latter half of the year.